SAB Biotherapeutics Inc (SABS)
3.69
-0.18
(-4.65%)
USD |
NASDAQ |
May 17, 16:00
3.69
0.00 (0.00%)
After-Hours: 20:00
SAB Biotherapeutics Total Assets (Quarterly): 83.94M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 83.94M |
| September 30, 2023 | 28.34M |
| June 30, 2023 | 35.44M |
| March 31, 2023 | 42.67M |
| December 31, 2022 | 50.90M |
| September 30, 2022 | 52.51M |
| Date | Value |
|---|---|
| June 30, 2022 | 59.15M |
| March 31, 2022 | 67.47M |
| December 31, 2021 | 81.14M |
| September 30, 2021 | 116.93M |
| June 30, 2021 | 54.21M |
| December 31, 2020 | 56.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.34M
Minimum
Sep 2023
116.93M
Maximum
Sep 2021
60.77M
Average
55.37M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.64M |
| Shareholders Equity (Quarterly) | 57.30M |